The Vegetarian Resource Group Blog

Medicago’s plant-based vaccine trial shows 75.3% efficacy against Delta variant

Posted on December 17, 2021 by The VRG Blog Editor

According to Reuters, “Canadian drug developer Medicago’s plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline’s (GSK.L) booster, was 75.3% effective against the Delta variant of the virus in a late stage study.” … “Medicago will imminently seek regulatory approval for the world’s first plant-based COVID-19 vaccine from Health Canada as part of its rolling submission.”

For article, see: https://www.reuters.com/business/healthcare-pharmaceuticals/medicagos-plant-based-vaccine-trial-shows-753-efficacy-against-delta-variant-2021-12-07/

This vaccine information may also be of interest:

How plant-based vaccines are developed?

https://vimeo.com/590991662

https://medicago.com/en/faq/

The contents of this posting, website, and our other publications, including The Vegetarian Journal, are not intended to provide personal medical advice. Medical advice should be obtained from a qualified health professional. We often depend on product and ingredient information from company statements. It is impossible to be 100% sure about a statement, info can change, people have different views, and mistakes can be made. Please use your best judgment about whether a product is suitable for you. To be sure, do further research or confirmation on your own.

Leave a Reply


  • Donate

  • Subscribe to the blog by RSS

  • VRG-NEWS

    Sign up for our newsletter to receive recipes, ingredient information, reviews of new products, announcements of new books, free samples of products, and other VRG materials.

    Your E-mail address:
    Your Name (optional):



↑ Top